Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Juvenile CML

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature

Abstract

Juvenile myelomonocytic leukaemia (JMML) is a rare paediatric disease and allogeneic stem cell transplantation is the only curative approach. The roles of pretransplant treatment, conditioning regimen and graft-versus-host disease (GVHD) are still unclear. Eleven children with JMML underwent allogeneic BMT in our institution. Donors were matched unrelated (n = 6) matched siblings (n = 4) and one mismatch family donor. Transplant-related mortality (TRM) was 36%. Three patients relapsed after transplantation. Two of three patients with relapse are in continuous remission after donor lymphocyte infusion or second BMT, respectively. To evaluate the role of pretransplant treatment, conditioning regimen and GVHD, we have summarised our series with other published single centre reports and give an overview on a total of 65 patients with JMML who underwent allogeneic BMT. No significant correlation between pretransplant treatment, conditioning regimen and TRM could be observed. Overall relapse rate is high (47%). TBI is associated with a significantly higher relapse rate (P = 0.012). Other conditioning modalities, intensive chemotherapy and splenectomy prior to stem cell transplantation do not seem to have a significant impact on relapse rate. Patients with or without GVHD showed no significant difference in relapse rate (58% vs 45%). In the event of relapse after transplantation withdrawal of immunosuppression, donor lymphocyte infusion or second transplant was successful in 6/11 patients. Graft-versus-leukaemia effect seems to play an essential role in bone marrow transplantation for JMML. Bone Marrow Transplantation (2000) 26, 377–382.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gadner H, Haas OA . Experience in pediatric myelodysplastic syndromes Hematol Oncol Clin North Am 1992 6: 655–672

    Article  CAS  PubMed  Google Scholar 

  2. Niemeyer CM, Arico M, Basso G et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) (see comments) Blood 1997 89: 3534–3543

    CAS  PubMed  Google Scholar 

  3. Luna-Fineman S, Shannon KM, Atwater SK et al. Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients Blood 1999 93: 459–466

    CAS  PubMed  Google Scholar 

  4. Miles DK, Freedman MH, Stephens K et al. Patterns of hematopoetic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders Blood 1996 88: 4314–4320

    CAS  PubMed  Google Scholar 

  5. Arico M, Biondi A, Pui CH . Juvenile Myelomonocytic leukemia Blood 1997 90: 479–488

    CAS  PubMed  Google Scholar 

  6. Diaz de Heredia C, Ortega JJ, Coll MT et al. Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study Med Pediatr Oncol 1998 31: 516–520

    Article  CAS  PubMed  Google Scholar 

  7. Passmore SJ, Hann IM, Stiller CA et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system Blood 1995 85: 1742–1750

    CAS  PubMed  Google Scholar 

  8. Arnold R, de Witte T, van Biezen A et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group Bone Marrow Transplant 1998 21: 1213–1216

    Article  CAS  PubMed  Google Scholar 

  9. Locatelli F, Niemeyer C, Angelucci E et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood J Clin Oncol 1997 15: 566–573

    Article  CAS  PubMed  Google Scholar 

  10. Przepiorka D, Weisdorf D, Martin P . Consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825–828

    CAS  PubMed  Google Scholar 

  11. Lion T, Müller-Berat N . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations Leukemia 1999 13: 2059

    Article  CAS  PubMed  Google Scholar 

  12. Kressler EJ, Haas OA, Konig M et al. Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia Leuk Lymphoma 1999 33: 597–600

    Article  CAS  PubMed  Google Scholar 

  13. Bunin NJ, Casper JT, Lawton C et al. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings Bone Marrow Transplant 1992 9: 119–122

    CAS  PubMed  Google Scholar 

  14. Chown SR, Potter MN, Cornish J et al. Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia Br J Haematol 1996 93: 674–676

    Article  CAS  PubMed  Google Scholar 

  15. Donadieu J, Stephan JL, Blanche S et al. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation (see comments) Bone Marrow Transplant 1994 13: 777–782

    CAS  PubMed  Google Scholar 

  16. Locatelli F, Pession A, Comoli P et al. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia Br J Haematol 1996 92: 49–54.

    Article  CAS  PubMed  Google Scholar 

  17. MacMillan ML, Davies SM, Orchard PJ et al. Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia Br J Haematol 1998 103: 552–558

    Article  CAS  PubMed  Google Scholar 

  18. Rassam SM, Katz F, Chessells JM, Morgan G . Successful allogeneic bone marrow transplantation in juvenile CML: conditioning or graft-versus-leukaemia effect? Bone Marrow Transplant 1993 11: 247–250

    CAS  PubMed  Google Scholar 

  19. Sanders JE, Buckner CD, Thomas ED et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia Blood 1988 71: 1144–1146

    CAS  PubMed  Google Scholar 

  20. Urban C, Schwinger W, Slavc I et al. Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia Bone Marrow Transplant 1990 5: 353–356

    CAS  PubMed  Google Scholar 

  21. Orchard PJ, Miller JS, McGlennen R et al. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia Bone Marrow Transplant 1998 22: 201–203

    Article  CAS  PubMed  Google Scholar 

  22. Lutz P, Zix KI, Souillet G et al. Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG) Bone Marrow Transplant 1996 18: 1111–1116

    CAS  PubMed  Google Scholar 

  23. Montagna D, Locatelli F, Calcaterra V et al. Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study Bone Marrow Transplant 1998 22: 743–750

    Article  CAS  PubMed  Google Scholar 

  24. Tsukada N, Kobata T, Aizawa Y et al. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation Blood 1999 93: 2738–2747

    CAS  PubMed  Google Scholar 

  25. Woolfrey AE, Gooley TA, Sievers EL et al. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome Blood 1998 92: 3546–3556

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matthes-Martin, S., Mann, G., Peters, C. et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature. Bone Marrow Transplant 26, 377–382 (2000). https://doi.org/10.1038/sj.bmt.1702522

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702522

Keywords

This article is cited by

Search

Quick links